Decoding Your GI and Pathology Reports
At a Glance
For FAP patients, pathology reports reveal cancer risk. Key warning signs include high-grade dysplasia and villous polyps. The Spigelman Stage (0-IV) calculates duodenal risk based on polyp size, number, and type, helping doctors determine your need for surveillance or preventive surgery.
After a colonoscopy or upper endoscopy, you will receive a pathology report that describes the tissue samples (biopsies) taken during the procedure. For someone with FAP, these reports can be dense with medical jargon. Understanding these terms helps you understand the “activity” of your condition and the urgency of your next steps.
Decoding Pathology Terms
When a pathologist looks at your polyps under a microscope, they are looking for specific features that indicate how close a polyp is to becoming cancerous.
- Adenoma: This is the most common term you will see. It simply means a precancerous polyp. In FAP, the goal is to manage these before they progress [1][2].
- Dysplasia: This refers to how “abnormal” the cells look.
- Polyp Architecture (Shape):
The Spigelman Staging System
While the colon is often the first focus, the duodenum (the first part of the small intestine) requires its own specialized scoring system. The Spigelman Stage (0 to IV) is calculated by adding points from four different categories found in your endoscopy and pathology reports [6][4].
How the Score is Calculated
Points are assigned (1, 2, or 3) for each of these four areas.
| Points | Number of Polyps | Size of Polyps | Histology (Type) | Dysplasia Grade |
|---|---|---|---|---|
| 1 point | 1–4 polyps | 1–4 mm | Tubular | Mild (Low-grade) |
| 2 points | 5–20 polyps | 5–10 mm | Tubulovillous | Moderate |
| 3 points | >20 polyps | >10 mm | Villous | Severe (High-grade) |
(Note: Modern pathology reports often group “Mild” and “Moderate” into “Low-grade” and label “Severe” as “High-grade”.)
What the Stages Mean
The points are added together to determine your Spigelman Stage [4]. If you have even a single small polyp, your minimum score is 4 points.
- Stage 0: 0 points. No polyps found.
- Stage I: 4 points. Very low risk; surveillance every 5 years.
- Stage II: 5–6 points. Mild disease; surveillance every 2–3 years.
- Stage III: 7–8 points. Moderate disease; surveillance every 6–12 months.
- Stage IV: 9–12 points. Severe disease. This stage carries the highest risk for cancer (up to 36% over 10 years) and often triggers a discussion about preventive surgery [7][8].
What a “Complete” Report Must Include
Because FAP is a specialized condition, a standard GI report may not be enough. For a report to be considered “complete” for an FAP patient, it should ideally mention:
- Scope Type: Use of a side-viewing duodenoscope is critical to properly see the ampulla of Vater, a common site for polyps that can be missed by standard scopes [9][10].
- Ampulla Description: The report should specifically describe the appearance of the ampulla and whether it was biopsied [11].
- Polyp Count and Distribution: Instead of “multiple polyps,” the report should estimate the total number (e.g., “>20”) to help with Spigelman staging [4].
- Stomach Check: Descriptions of fundic gland polyps in the stomach, noting if any show “atypical” features [12].
Common questions in this guide
What is the Spigelman Staging System for FAP?
What does high-grade dysplasia mean on my polyp biopsy?
What is the difference between tubular and villous polyps?
Why do FAP patients need a side-viewing duodenoscope?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What was my final Spigelman score and Stage based on this latest procedure?
- 2.Did you use a side-viewing scope (duodenoscope) to look at my ampulla of Vater?
- 3.Were there any signs of high-grade dysplasia or villous growth in the polyps you biopsied?
- 4.Based on the number and size of polyps found, when should my next surveillance endoscopy be scheduled?
- 5.If I am at Stage III or IV, are we considering 'downstaging' with intensive endoscopy or discussing surgical options?
- 6.Did you see any fundic gland polyps in my stomach, and do they show any 'atypical' features?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Targeted next-generation sequencing approach for molecular genetic diagnosis of hereditary colorectal cancer: Identification of a novel single nucleotide germline insertion in adenomatous polyposis coli gene causes familial adenomatous polyposis.
Wang D, Liang S, Zhang X, et al.
Molecular genetics & genomic medicine 2019; (7(1)):e00505 doi:10.1002/mgg3.505.
PMID: 30523670 - 2
Exome Sequencing Identifies Biallelic MSH3 Germline Mutations as a Recessive Subtype of Colorectal Adenomatous Polyposis.
Adam R, Spier I, Zhao B, et al.
American journal of human genetics 2016; (99(2)):337-51.
PMID: 27476653 - 3
T cell migration and effector function differences in familial adenomatous polyposis patients with APC gene mutations.
Cuche C, Mastrogiovanni M, Juzans M, et al.
Frontiers in immunology 2023; (14()):1163466 doi:10.3389/fimmu.2023.1163466.
PMID: 37533857 - 4
Spigelman stage IV duodenal polyposis does not precede most duodenal cancer cases in patients with familial adenomatous polyposis.
Thiruvengadam SS, Lopez R, O'Malley M, et al.
Gastrointestinal endoscopy 2019; (89(2)):345-354.e2 doi:10.1016/j.gie.2018.07.033.
PMID: 30081000 - 5
Surveillance of Duodenal Polyposis in Familial Adenomatous Polyposis: Should the Spigelman Score Be Modified?
Sourrouille I, Lefèvre JH, Shields C, et al.
Diseases of the colon and rectum 2017; (60(11)):1137-1146 doi:10.1097/DCR.0000000000000903.
PMID: 28991077 - 6
The impact of chromoendoscopy for surveillance of the duodenum in patients with MUTYH-associated polyposis and familial adenomatous polyposis.
Hurley JJ, Thomas LE, Walton SJ, et al.
Gastrointestinal endoscopy 2018; (88(4)):665-673 doi:10.1016/j.gie.2018.04.2347.
PMID: 29702101 - 7
Pancreas- and Pylorus-Preserving Duodenectomy for Advanced Familial Duodenal Polyposis.
Leite JS, Tralhão JG, Manso A, et al.
GE Portuguese journal of gastroenterology 2020; (27(3)):185-191 doi:10.1159/000503010.
PMID: 32509924 - 8
Endoscopic management of duodenal adenomatosis in familial adenomatous polyposis-A case-based review.
Soons E, Bisseling TM, van Kouwen MCA, et al.
United European gastroenterology journal 2021; (9(4)):461-468 doi:10.1002/ueg2.12071.
PMID: 34529357 - 9
Full spectrum endoscopy for an easy and adequate visualization of Vater's papilla.
Papanikolaou IS, Tziatzios G, Gkolfakis P, Triantafyllou K
Annals of translational medicine 2018; (6(13)):267 doi:10.21037/atm.2018.04.34.
PMID: 30094253 - 10
Efficacy of Full-Spectrum Endoscopy to Visualize the Major Duodenal Papilla in Patients with Familial Adenomatous Polyposis.
Ichijima R, Abe S, Kobayashi S, et al.
Digestion 2020; (101(5)):563-570 doi:10.1159/000501476.
PMID: 31311010 - 11
Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Vanbiervliet G, Strijker M, Arvanitakis M, et al.
Endoscopy 2021; (53(4)):429-448 doi:10.1055/a-1397-3198.
PMID: 33728632 - 12
Endoscopic Surveillance of Duodenal Polyposis After Total Gastrectomy in Familial Adenomatous Polyposis.
Shah RS, Mehta N, Mankaney G, et al.
ACG case reports journal 2020; (7(8)):e00445 doi:10.14309/crj.0000000000000445.
PMID: 32903873
This page explains FAP pathology and endoscopy terminology for educational purposes only. Your gastroenterologist and pathologist are the best sources for interpreting your specific Spigelman stage and report.
Get notified when new evidence is published on Familial Adenomatous Polyposis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.